CD8a, Fc Fusion, Avi-Tag, Biotin-Labeled, HiP™ Recombinant

Only %1 left
Catalog #
101871
As low as $290 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human CD8a (cluster of differentiation 8 a) transcript 1 encompassing amino acids 22-182. This construct contains a C-terminal Fc domain followed by an Avi-Tag™. The recombinant protein was affinity purified. HiP™ indicates a high purity protein (≥90% pure) with less than 10% aggregation as measured by gel filtration.

Synonyms
T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2, CD8a, CD8A, MAL
Product Info
Storage and Usage
Citations
Species
Human
Construct
CD8a (22-182-Fc(lgG1)-Avi)-(Biotin)
Host Species/Expression System
HEK293
Purity

≥90%

Format

Aqueous buffer solution

Formulation

8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

MW
47 kDa + glycans
Amino Acids
22-182
Glycosylation
This protein runs at a higher MW by SDS-PAGE due to glycosylation.
Aggregation
<10%
Genbank #
NM_001768.7
UniProt #
P01732
Tag(s)
C-terminal Avi-Tag™
Label

This protein is enzymatically biotinylated using Avi-Tag™ technology. Biotinylation was confirmed to be ≥90%.

For more information on enzymatic biotinylation, please see our Tech Note

Background

CD8 is a co-receptor for the TCR (T cell receptor) in T cells, binding to MHC (major histocompatibility complex) class I proteins. CD8 is a typical marker of cytotoxic T cells and is involved in signaling. CD8 has two isoforms, a and b. CD8b recruits Lck (lymphocyte-specific protein tyrosine kinase) to the TCR-CD3 complex, and Lck phosphorylates multiple proteins involved in activation of cytotoxic T lymphocytes. It is thus critical for the lysis of cancer cells.